December 10th, 2024
Observation Period Completed for Primary Endpoint – Phase II Clinical Trial in Patients with Angiosarcoma
We are pleased to announce the completion of the 90-day observation period for ……
We are pleased to announce the completion of the 90-day observation period for ……
The paper titled “Poly(vinyl alcohol) potentiating an inert D-amino acid-based ……